Global Oncolytic Virus Therapy Market Report 2024

Oncolytic Virus Therapy Global Market Report 2024 – By Therapy Type (HSV-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, NDV (Newcastle Disease Virus), Other Therapy Types), By Virus Type (Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses), By Application (Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer), By End-User (Hospitals, Specialty Clinics, Cancer Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033

Oncolytic Virus Therapy Global Market Report 2024

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs
Customise Your Report
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying
Oncolytic Virus Therapy Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Oncolytic Virus Therapy Market Definition And Segments

Oncolytic virus therapy, also known as virotherapy, is a type of cancer treatment that utilizes viruses to target and destroy cancer cells in the body. The main objective of oncolytic virus therapy is to use viruses that have been genetically modified or naturally occur in a way that allows them to selectively infect and replicate within cancer cells while sparing healthy cells.

The main types of oncolytic virus therapy are HSV-based oncolytic virus therapy, adenovirus-based oncolytic virus therapy, reovirus, poxviruses, Newcastle disease virus (NDV), and others. HSV-based oncolytic virus therapy utilizes the herpes simplex virus (HSV) as the platform for treatment. The various virus types include genetically engineered oncolytic viruses and oncolytic wild-type viruses. These are used in various applications such as breast cancer, lung cancer, prostate cancer, melanoma, brain tumor, and blood cancer and are also used by end-users such as hospitals, specialty clinics, and cancer research institutes.

The oncolytic virus therapy market covered in this report is segmented –

1) By Therapy Type: HSV-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, NDV (Newcastle Disease Virus), Other Therapy Types

2) By Virus Type: Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses

3) By Application: Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer

4) By End-User: Hospitals, Specialty Clinics, Cancer Research Institutes

The oncolytic virus therapy market size has grown exponentially in recent years. It will grow from $0.15 billion in 2023 to $0.19 billion in 2024 at a compound annual growth rate (CAGR) of 26.2%. The growth in the historic period can be attributed to improved genetic engineering techniques, increased understanding of tumor microenvironment, clinical successes and regulatory approvals, the rise of immunotherapy in cancer treatment, and advancements in gene delivery systems.

The oncolytic virus therapy market size is expected to see exponential growth in the next few years. It will grow to $0.44 billion in 2028 at a compound annual growth rate (CAGR) of 23.9%. The growth in the forecast period can be attributed to the expansion of oncolytic virus platforms, combination therapies with immune checkpoint inhibitors, personalized medicine approaches, expansion of the clinical trial landscape, regulatory support and guidelines. Major trends in the forecast period include technological advances in delivery systems, advancements in synthetic biology, collaborations and partnerships in the biopharmaceutical industry, advancements in virology and immunology, focus on pediatric oncology.

Rising Cancer Prevalence Drives Growth In The Oncolytic Virus Therapy Market

The increasing prevalence of cancer cases is expected to propel the growth of the oncolytic virus therapy market going forward. Cancer is a term used to describe a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. Oncolytic virus therapy offers the potential to selectively target and destroy cancer cells while stimulating an immune response against the tumor, providing a dual mechanism of action for effective cancer treatment. For instance, in January 2023, according to the American Cancer Society Inc., a US-based non-profit organization, it is anticipated that there will be 609,820 cancer deaths and 1,958,310 new cancer cases in the US during 2022. Therefore, the increasing prevalence of cancer cases is driving the growth of the oncolytic virus therapy market.

Surge In Ongoing Clinical Trials Catalyzes Growth In The Oncolytic Virus Therapy Market

A growing number of ongoing clinical trials is expected to propel the growth of the oncolytic virus therapy market going forward. Clinical trials are research studies conducted with human participants to evaluate the safety and effectiveness of new medical treatments, interventions, or diagnostic procedures. Increasing clinical trials utilize oncolytic virus therapy due to its potential to selectively target and destroy cancer cells while sparing healthy tissue. For instance, in October 2023, according to ClinicalTrials.gov, a part of the National Institutes of Health (NIH), a US-based government agency responsible for conducting and supporting medical research, the number of registered studies increased from 437,523 in 2022 to 468,457 in all 50 states of the United States and across 221 countries. Moreover, it was reported that 143,613 studies (31% of the total) are registered in the U.S. only, while 251,159 studies (54% of the total) are registered in non-U.S. locations. Therefore, a growing number of ongoing clinical trials is driving the growth of the oncolytic virus therapy market.

Major companies operating in the oncolytic virus therapy market report are Pfizer Inc., Johnson & Johnson, Sorrento Therapeutics Inc., AbbVie Inc., AstraZeneca PLC, Amgen Inc., Boehringer Ingelheim Group, Regeneron Pharmaceuticals, Daiichi Sankyo Company Limited, Eurofins Scientific SE, Recipharm AB, Kissei Pharmaceutical Co. Ltd., Takara Bio Inc., Oncorus Inc., Replimune Inc., Vyriad Inc., Genelux Corporation, Oncolys BioPharma Inc., Adze Biotechnology, Oncolytics Biotech Inc., TILT Biotherapeutics Ltd., Transgene SA, Circio Holding ASA, Lokon Pharma AB, Provectus Biopharmaceuticals Inc., Vibalogics, SillaJen Inc.

Innovation Redefines Oncolytic Virus Therapy For Primary Brain Cancer

Product innovations are a key trend gaining popularity in the oncolytic virus therapy market. Major companies operating in the oncolytic virus therapy market are focused on introducing innovative products to sustain their position in the market. For instance, in November 2021, Daiichi Sankyo Company Limited, a Japan-based pharmaceutical company, launched DELYTACT in Japan. This is the first oncolytic virus approved for primary brain cancer in any region, including genetically engineered oncolytic herpes simplex virus type 1 (HSV-1). The virus selectively replicates and kills tumor cells without affecting normal tissues.

Strategic Partnerships Drive Innovations In Oncolytic Virus Therapy Market

Major companies operating in the oncolytic virus therapy industry are adopting strategic partnerships approach to provide advanced and comprehensive cancer treatments. Strategic partnerships refer to a process in which companies leverage each other’s strengths and resources to achieve mutual benefits and success. For instance, in July 2023, RenovoRx Inc., a US-based clinical-stage biopharmaceutical company, partnered with Imugene Ltd., an Australia-based clinical-stage immuno-oncology company. With this partnership, they aim to enter into a strategic research collaboration to optimize the delivery of Imugene’s oncolytic virus therapy with RenovoRx’s TAMP (Trans-Arterial Micro-Perfusion) therapy platform for the treatment of difficult-to-access tumors and also investigate the ability to administer Imugene’s CF33 oncolytic virus technology with RenovoRx’s TAMP therapy platform.

Recipharm AB Strengthens Global Portfolio With Acquisition Of Vibalogics To Expand Oncolytic Virus Manufacturing Capabilities

In April 2022, Recipharm AB, a Sweden-based pharmaceutical company, acquired Vibalogics for an undisclosed amount. With this acquisition, Recipharm AB expanded its global business through a robust end-to-end offering with development capabilities, GMP drug substance and drug product manufacture, sterile fill & finish, and analytical and quality control testing. Vibalogics is a Germany-based biotechnology company, a contract development and manufacturing organization (CDMO) focused on manufacturing oncolytic viruses, viral vaccines, and gene therapies.

North America was the largest region in the oncolytic virus therapy market in 2023 and is expected to be the fastest-growing region in the forecast period. The regions covered in the oncolytic virus therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the oncolytic virus therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The oncolytic virus therapy market includes revenues earned by entities by providing seneca valley virus (SVV), semliki forest virus (SFV), vesicular stomatitis virus (VSV), and sindbis virus (SBV). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The oncolytic virus therapy market research report is one of a series of new reports from The Business Research Company that provides oncolytic virus therapy market statistics, including oncolytic virus therapy industry global market size, regional shares, competitors with an oncolytic virus therapy market share, detailed oncolytic virus therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the oncolytic virus therapy industry. This oncolytic virus therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Oncolytic Virus Therapy Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $0.19 billion
Revenue Forecast In 2033 $0.44 billion
Growth Rate CAGR of 23.9% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Therapy Type: HSV-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, NDV (Newcastle Disease Virus), Other Therapy Types
2) By Virus Type: Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses
3) By Application: Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer
4) By End-User: Hospitals, Specialty Clinics, Cancer Research Institutes
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; Johnson & Johnson; Sorrento Therapeutics Inc.; AbbVie Inc.; AstraZeneca plc; Amgen Inc.; Boehringer Ingelheim Group; Regeneron Pharmaceuticals; Daiichi Sankyo Company Limited; Eurofins Scientific SE; Recipharm AB; Kissei Pharmaceutical Co. Ltd.; Takara Bio Inc.; Oncorus Inc.; Replimune Inc.; Vyriad Inc.; Genelux Corporation; Oncolys BioPharma Inc.; Adze Biotechnology; Oncolytics Biotech Inc.; TILT Biotherapeutics Ltd.; Transgene SA; Circio Holding ASA; Lokon Pharma AB; Provectus Biopharmaceuticals Inc.; Vibalogics; SillaJen Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Oncolytic Virus Therapy Market Characteristics

    3. Oncolytic Virus Therapy Market Trends And Strategies

    4. Oncolytic Virus Therapy Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Oncolytic Virus Therapy Market Size and Growth

    5.1. Global Oncolytic Virus Therapy Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Oncolytic Virus Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Oncolytic Virus Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Oncolytic Virus Therapy Market Segmentation

    6.1. Global Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    HSV-Based Oncolytic Virus Therapy

    Adenovirus-Based Oncolytic Virus Therapy

    Reovirus

    Poxviruses

    Newcastle Disease Virus (NDV)

    Other Therapy Types

    6.2. Global Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Genetically Engineered Oncolytic Viruses

    Oncolytic Wild-Type Viruses

    6.3. Global Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Breast Cancer

    Lung Cancer

    Prostate Cancer

    Melanoma

    Brain Tumor

    Blood Cancer

    6.4. Global Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Specialty Clinics

    Cancer Research Institutes

    7. Oncolytic Virus Therapy Market Regional And Country Analysis

    7.1. Global Oncolytic Virus Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Oncolytic Virus Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Oncolytic Virus Therapy Market

    8.1. Asia-Pacific Oncolytic Virus Therapy Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Oncolytic Virus Therapy Market

    9.1. China Oncolytic Virus Therapy Market Overview

    9.2. China Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Oncolytic Virus Therapy Market

    10.1. India Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Oncolytic Virus Therapy Market

    11.1. Japan Oncolytic Virus Therapy Market Overview

    11.2. Japan Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Oncolytic Virus Therapy Market

    12.1. Australia Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Oncolytic Virus Therapy Market

    13.1. Indonesia Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Oncolytic Virus Therapy Market

    14.1. South Korea Oncolytic Virus Therapy Market Overview

    14.2. South Korea Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Oncolytic Virus Therapy Market

    15.1. Western Europe Oncolytic Virus Therapy Market Overview

    15.2. Western Europe Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Oncolytic Virus Therapy Market

    16.1. UK Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Oncolytic Virus Therapy Market

    17.1. Germany Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Oncolytic Virus Therapy Market

    18.5. France Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Oncolytic Virus Therapy Market

    19.9. Italy Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Oncolytic Virus Therapy Market

    20.13. Spain Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Oncolytic Virus Therapy Market

    21.1. Eastern Europe Oncolytic Virus Therapy Market Overview

    21.2. Eastern Europe Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Oncolytic Virus Therapy Market

    22.1. Russia Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Oncolytic Virus Therapy Market

    23.1. North America Oncolytic Virus Therapy Market Overview

    23.2. North America Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Oncolytic Virus Therapy Market

    24.1. USA Oncolytic Virus Therapy Market Overview

    24.2. USA Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Oncolytic Virus Therapy Market

    25.1. Canada Oncolytic Virus Therapy Market Overview

    25.2. Canada Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Oncolytic Virus Therapy Market

    26.1. South America Oncolytic Virus Therapy Market Overview

    26.2. South America Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Oncolytic Virus Therapy Market

    27.1. Brazil Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Oncolytic Virus Therapy Market

    28.1. Middle East Oncolytic Virus Therapy Market Overview

    28.2. Middle East Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Oncolytic Virus Therapy Market

    29.1. Africa Oncolytic Virus Therapy Market Overview

    29.2. Africa Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Oncolytic Virus Therapy Market Competitive Landscape And Company Profiles

    30.1. Oncolytic Virus Therapy Market Competitive Landscape

    30.2. Oncolytic Virus Therapy Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Johnson & Johnson

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Sorrento Therapeutics Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. AbbVie Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. AstraZeneca plc

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Oncolytic Virus Therapy Market Other Major And Innovative Companies

    31.1. Amgen Inc.

    31.2. Boehringer Ingelheim Group

    31.3. Regeneron Pharmaceuticals

    31.4. Daiichi Sankyo Company Limited

    31.5. Eurofins Scientific SE

    31.6. Recipharm AB

    31.7. Kissei Pharmaceutical Co. Ltd.

    31.8. Takara Bio Inc.

    31.9. Oncorus Inc.

    31.10. Replimune Inc.

    31.11. Vyriad Inc.

    31.12. Genelux Corporation

    31.13. Oncolys BioPharma Inc.

    31.14. Adze Biotechnology

    31.15. Oncolytics Biotech Inc.

    32. Global Oncolytic Virus Therapy Market Competitive Benchmarking

    33. Global Oncolytic Virus Therapy Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Oncolytic Virus Therapy Market

    35. Oncolytic Virus Therapy Market Future Outlook and Potential Analysis

    35.1 Oncolytic Virus Therapy Market In 2028 - Countries Offering Most New Opportunities

    35.2 Oncolytic Virus Therapy Market In 2028 - Segments Offering Most New Opportunities

    35.3 Oncolytic Virus Therapy Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Oncolytic Virus Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Oncolytic Virus Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Pfizer Inc. Financial Performance
  • Table 76: Johnson & Johnson Financial Performance
  • Table 77: Sorrento Therapeutics Inc. Financial Performance
  • Table 78: AbbVie Inc. Financial Performance
  • Table 79: AstraZeneca plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Oncolytic Virus Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Oncolytic Virus Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Pfizer Inc. Financial Performance
  • Figure 76: Johnson & Johnson Financial Performance
  • Figure 77: Sorrento Therapeutics Inc. Financial Performance
  • Figure 78: AbbVie Inc. Financial Performance
  • Figure 79: AstraZeneca plc Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Cancer Vaccines Global Market Report 2024 – By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), By Cancer Type (Prostate, Cervical, Colorectal, Throat, Other Cancer Types), By End-User (Cancer Treatment Centers, Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Anti-Cancer MAbS Global Market Report 2024 – By Type (Murine Antibodies, Chimeric Antibodies, Humanized Antibodies, Other Types), By Application (Blood Cancer, Breast Cancer, Lung Cancer, Melanoma, Colorectal Cancer, Liver Cancer, Other Applications), By End User (Hospitals, Research Institutes, Other End Users ) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Solid Tumor Cancer Treatment Global Market Report 2024 – By Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, Surgical Procedures), By Application (Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Other Applications ), By End-Users (Hospitals, Research Institutes, Homecare) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cancer Profiling Global Market Report 2024 – By Technology (Immunoassays, PCR (Polymerized Chain Reaction), NGS (Next-Generation Sequencing), Microarrays, In-Situ Hybridization), By Biomarker Type (Genomic Biomarkers, Protein Biomarkers), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Other Cancers), By Application (Research Applications, Clinical Applications, Screening, Diagnostics, Prognostics, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Intratumoral Cancer Therapies Global Market Report 2024 – By Technology (Monoclonal Antibodies, Vaccines, Checkpoint Inhibitors, Cell Therapies, Immunes System Modulator, Adoptive Cell Transfer, Cytokines ), By Application (Lung Cancer, Breast Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Other Applications ), By End Users (Hospitals, Cancer Research Centers, Clinics) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Endometrial Cancer Treatment Global Market Report 2024 – By Type (Adenocarcinoma, Uterine Carcinosarcoma, Squamous Cell Carcinoma, Small Cell Carcinoma, Transitional Carcinoma, Serous Carcinoma, Other Types), By Diagnosis Method (Biopsy, Pelvic Ultrasound, Hysteroscopy, CT Scan, Other Diagnosis Methods), By Route Of Administration (Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Metastatic Breast Cancer Treatment Global Market Report 2024 – By Therapy Type (Chemotherapy, Radiation Therapy, Biologic Targeted Therapy, Breast Surgery, Hormone Therapy), By Molecule Type (Monoclonal Antibody, Peptides, Polymer, Small Molecule, Gene Therapy), By Route Of Administration (Oral, Parenteral), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cervical Cancer Vaccine Global Market Report 2024 – By Type (Cervarix, Gardasil, Gardasil 9), By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-Users (Hospital, Biotechnology Company, Academic And Research Organizations, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the oncolytic virus therapy market?

Oncolytic virus therapy, also known as virotherapy, is a type of cancer treatment that utilizes viruses to target and destroy cancer cells in the body. The main objective of oncolytic virus therapy is to use viruses that have been genetically modified or naturally occur in a way that allows them to selectively infect and replicate within cancer cells while sparing healthy cells. For further insights on the oncolytic virus therapy market, request a sample here

How will the oncolytic virus therapy market drivers and restraints affect the oncolytic virus therapy market dynamics? What forces will shape the oncolytic virus therapy industry going forward?

The oncolytic virus therapy market major growth driver - Rising Cancer Prevalence Drives Growth In The Oncolytic Virus Therapy Market. For further insights on the oncolytic virus therapy market, request a sample here

What is the forecast market size or the forecast market value of the oncolytic virus therapy market?

The oncolytic virus therapy market size has grown exponentially in recent years. It will grow from $0.15 billion in 2023 to $0.19 billion in 2024 at a compound annual growth rate (CAGR) of 26.2%. The growth in the historic period can be attributed to improved genetic engineering technique, increased understanding of tumor microenvironment, clinical successes and regulatory approvals, rise of immunotherapy in cancer treatment, advancements in gene delivery systems. The oncolytic virus therapy market size is expected to see exponential growth in the next few years. It will grow to $0.44 billion in 2028 at a compound annual growth rate (CAGR) of 23.9%. The growth in the forecast period can be attributed to expansion of oncolytic virus platforms, combination therapies with immune checkpoint inhibitors, personalized medicine approaches, expansion of clinical trial landscape, regulatory support and guidelines. Major trends in the forecast period include technological advances in delivery systems, advancements in synthetic biology, collaborations and partnerships in biopharmaceutical industry, advancements in virology and immunology, focus on pediatric oncology. For further insights on the oncolytic virus therapy market, request a sample here

How is the oncolytic virus therapy market segmented?

The oncolytic virus therapy market is segmented
1) By Therapy Type: HSV-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, NDV (Newcastle Disease Virus), Other Therapy Types
2) By Virus Type: Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses
3) By Application: Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer
4) By End-User: Hospitals, Specialty Clinics, Cancer Research InstitutesFor further insights on the oncolytic virus therapy market, request a sample here

Which region has the largest share of the oncolytic virus therapy market? What are the other regions covered in the report?

North America was the largest region in the oncolytic virus therapy market in 2023, and is expected to be the fastest-growing region in the forecast period. The regions covered in the oncolytic virus therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the oncolytic virus therapy market, request a sample here.

Who are the major players in the oncolytic virus therapy market?

Major companies operating in the oncolytic virus therapy market report are Pfizer Inc., Johnson & Johnson, Sorrento Therapeutics Inc., AbbVie Inc., AstraZeneca plc, Amgen Inc., Boehringer Ingelheim Group, Regeneron Pharmaceuticals, Daiichi Sankyo Company Limited, Eurofins Scientific SE, Recipharm AB, Kissei Pharmaceutical Co. Ltd., Takara Bio Inc., Oncorus Inc., Replimune Inc., Vyriad Inc., Genelux Corporation, Oncolys BioPharma Inc., Adze Biotechnology, Oncolytics Biotech Inc., TILT Biotherapeutics Ltd., Transgene SA, Circio Holding ASA, Lokon Pharma AB, Provectus Biopharmaceuticals Inc., Vibalogics, SillaJen Inc. For further insights on the oncolytic virus therapy market, request a sample here.

What are the key trends in the oncolytic virus therapy market?

Major trend in the oncolytic virus therapy market - Innovation Redefines Oncolytic Virus Therapy For Primary Brain Cancer. For further insights on the oncolytic virus therapy market, request a sample here.

What are the major opportunities in the oncolytic virus therapy market? What are the strategies for the oncolytic virus therapy market?

For detailed insights on the major opportunities and strategies in the oncolytic virus therapy market, request a sample here.

How does the oncolytic virus therapy market relate to the overall economy and other similar markets?

For detailed insights on oncolytic virus therapy market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the oncolytic virus therapy industry?

For detailed insights on the mergers and acquisitions in the oncolytic virus therapy industry, request a sample here.

What are the key dynamics influencing the oncolytic virus therapy market growth? SWOT analysis of the oncolytic virus therapy market.

For detailed insights on the key dynamics influencing the oncolytic virus therapy market growth and SWOT analysis of the oncolytic virus therapy industry, request a sample here.